SLC12A2 and Hydrocephalus: Interventions in the early stage of hydrocephalus (within 3 days) may reduce the abnormal secretion of cerebrospinal fluid and the occurrence of hydrocephalus by inhibiting the activation of TLR4/NF‐κB/NKCC1 pathway.